Various chronic diseases
New drugs available on the NHS for chronic lymphocytic leukaemia. NICE has issued two pieces of final guidance recommending obinutuzumab …. more
(Gazyvaro, Roche) and ofatumumab .…more
(Arzerra, Novartis), which are each given in combination with chlorambucil, for people with previously untreated chronic lymphocytic leukaemia if treatments containing fludarabine or bendamustine are not suitable. Both drugs are recommended on the basis that they will be provided to the NHS at a reduced price.
New lung cancer drug recommended in final draft guidance: Nintedanib is recommended as an option for treating locally advanced, metastatic or locally recurrent non small cell lung cancer that has progressed after first-line chemotherapy . …more